| Net Loss per Share |
12. Net Loss per Share
Diluted loss per share is the same as basic loss per share for all periods presented because the effects of potentially dilutive items were anti-dilutive given the Company’s net loss. The following securities have been excluded from the calculation of weighted average common shares outstanding because the effect is anti-dilutive:
|
|
|
Three and Six Months Ended June 30, |
|
|
|
|
2013 |
|
2014 |
|
|
Redeemable convertible preferred stock: |
|
|
|
|
|
|
Series A |
|
10,033,976 |
|
— |
|
|
Series B |
|
5,057,901 |
|
— |
|
|
Series C |
|
4,429,601 |
|
— |
|
|
Series D |
|
3,979,730 |
|
— |
|
|
Warrants to purchase Series D redeemable convertible preferred stock |
|
12,797 |
|
— |
|
|
Stock options |
|
5,604,989 |
|
6,388,908 |
|
|
Restricted stock units |
|
— |
|
1,001,390 |
|
Basic and diluted net loss per share attributable to common stockholders is calculated as follows:
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
|
|
2013 |
|
2014 |
|
2013 |
|
2014 |
|
|
Numerator (in thousands): |
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders |
|
$ |
(8,982 |
) |
$ |
(10,597 |
) |
$ |
(12,815 |
) |
$ |
(17,734 |
) |
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding, basic and diluted |
|
7,398,059 |
|
39,304,884 |
|
7,392,129 |
|
23,588,330 |
|
|
Net loss per share attributable to common stockholders, basic and diluted |
|
$ |
(1.21 |
) |
$ |
(0.27 |
) |
$ |
(1.73 |
) |
$ |
(0.75 |
) |
|